Latest News about BNTX
Recent news which mentions BNTX
BioNTech Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
March 07, 2025
From Benzinga
FDA Places Clinical Hold On BioNTech's Early-Phase Trial For RNA-Based Malaria Vaccine
March 05, 2025
From Benzinga
Electronic Arts Posts Upbeat Earnings, Joins Mattel, Johnson Controls, Mueller Water Products And Other Big Stocks Moving Higher On Wednesday
February 05, 2025
From Benzinga
3 Dirt-Cheap Stocks to Buy in a Market That's Priced for Perfection
January 22, 2025
From Motley Fool
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
January 19, 2025
From Benzinga
Why BioNTech (BNTX) Shares Are Volatile Today
January 13, 2025
From Benzinga
From Benzinga
Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside
January 07, 2025
From Benzinga
5 Predictions for the Stock Market in 2025 -- and Which Stocks Will Soar the Most If They're Right
January 04, 2025
From Motley Fool
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
December 18, 2024
From Motley Fool
Critical Insights From BioNTech Analyst Ratings: What You Need To Know
December 11, 2024
Tickers
BNTX
From Benzinga
2 Healthcare Stocks to Buy Hand Over Fist and 1 to Avoid
December 11, 2024
From Motley Fool
2 No-Brainer Stocks to Buy Before the End of 2024
December 09, 2024
From Motley Fool
Why Is BioNTech Stock Trading Higher On Friday?
December 06, 2024
From Benzinga
5 Top Stocks to Buy in December
December 04, 2024
From Motley Fool
This BioNTech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
November 19, 2024
From Benzinga
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
November 15, 2024
From Benzinga
European And US Vaccine Stocks Are Under Pressure - Here's WHy
November 15, 2024
From Benzinga
BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition
November 13, 2024
From Benzinga
BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential
November 09, 2024
From Benzinga
From Benzinga
Trump's Potential 'Health Czar' Robert F. Kennedy Jr. Rattles Vaccine Stocks: 'Shoot First Reaction'
November 07, 2024
From Benzinga
BioNTech Variant-adapted COVID-19 Vaccines Do Well In Q3
November 04, 2024
From Benzinga
Up Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising?
October 24, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.